128 related articles for article (PubMed ID: 30996806)
1. Novel Compounds Targeting the RNA-Binding Protein HuR. Structure-Based Design, Synthesis, and Interaction Studies.
Della Volpe S; Nasti R; Queirolo M; Unver MY; Jumde VK; Dömling A; Vasile F; Potenza D; Ambrosio FA; Costa G; Alcaro S; Zucal C; Provenzani A; Di Giacomo M; Rossi D; Hirsch AKH; Collina S
ACS Med Chem Lett; 2019 Apr; 10(4):615-620. PubMed ID: 30996806
[TBL] [Abstract][Full Text] [Related]
2. Exploration of ligand binding modes towards the identification of compounds targeting HuR: a combined STD-NMR and Molecular Modelling approach.
Vasile F; Della Volpe S; Ambrosio FA; Costa G; Unver MY; Zucal C; Rossi D; Martino E; Provenzani A; Hirsch AKH; Alcaro S; Potenza D; Collina S
Sci Rep; 2018 Sep; 8(1):13780. PubMed ID: 30214075
[TBL] [Abstract][Full Text] [Related]
3. Identification of N,N-arylalkyl-picolinamide derivatives targeting the RNA-binding protein HuR, by combining biophysical fragment-screening and molecular hybridization.
Della Volpe S; Linciano P; Listro R; Tumminelli E; Amadio M; Bonomo I; Elgaher WAM; Adam S; Hirsch AKH; Boeckler FM; Vasile F; Rossi D; Collina S
Bioorg Chem; 2021 Nov; 116():105305. PubMed ID: 34482166
[TBL] [Abstract][Full Text] [Related]
4. BOPC1 Enantiomers Preparation and HuR Interaction Study. From Molecular Modeling to a Curious DEEP-STD NMR Application.
Volpe SD; Listro R; Parafioriti M; Di Giacomo M; Rossi D; Ambrosio FA; Costa G; Alcaro S; Ortuso F; Hirsch AKH; Vasile F; Collina S
ACS Med Chem Lett; 2020 May; 11(5):883-888. PubMed ID: 32435400
[TBL] [Abstract][Full Text] [Related]
5. The C-terminal RNA binding motif of HuR is a multi-functional domain leading to HuR oligomerization and binding to U-rich RNA targets.
Scheiba RM; de Opakua AI; Díaz-Quintana A; Cruz-Gallardo I; Martínez-Cruz LA; Martínez-Chantar ML; Blanco FJ; Díaz-Moreno I
RNA Biol; 2014; 11(10):1250-61. PubMed ID: 25584704
[TBL] [Abstract][Full Text] [Related]
6. Compounds Interfering with Embryonic Lethal Abnormal Vision (ELAV) Protein-RNA Complexes: An Avenue for Discovering New Drugs.
Nasti R; Rossi D; Amadio M; Pascale A; Unver MY; Hirsch AKH; Collina S
J Med Chem; 2017 Oct; 60(20):8257-8267. PubMed ID: 28587461
[TBL] [Abstract][Full Text] [Related]
7. Identification of HuR-RNA Interfering Compounds by Dynamic Combinatorial Chemistry and Fluorescence Polarization.
Volpe SD; Listro R; Ambrosio FA; Garbagnoli M; Linciano P; Rossi D; Costa G; Alcaro S; Vasile F; Hirsch AKH; Collina S
ACS Med Chem Lett; 2023 Nov; 14(11):1509-1516. PubMed ID: 37970588
[TBL] [Abstract][Full Text] [Related]
8. Hu Antigen R (HuR) Protein Structure, Function and Regulation in Hepatobiliary Tumors.
Lachiondo-Ortega S; Delgado TC; Baños-Jaime B; Velázquez-Cruz A; Díaz-Moreno I; Martínez-Chantar ML
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681645
[TBL] [Abstract][Full Text] [Related]
9. Emerging role of HuR in inflammatory response in kidney diseases.
Shang J; Zhao Z
Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):753-763. PubMed ID: 28910975
[TBL] [Abstract][Full Text] [Related]
10. Interfering with HuR-RNA Interaction: Design, Synthesis and Biological Characterization of Tanshinone Mimics as Novel, Effective HuR Inhibitors.
Manzoni L; Zucal C; Maio DD; D'Agostino VG; Thongon N; Bonomo I; Lal P; Miceli M; Baj V; Brambilla M; Cerofolini L; Elezgarai S; Biasini E; Luchinat C; Novellino E; Fragai M; Marinelli L; Provenzani A; Seneci P
J Med Chem; 2018 Feb; 61(4):1483-1498. PubMed ID: 29313684
[TBL] [Abstract][Full Text] [Related]
11. Activity-dependent expression of ELAV/Hu RBPs and neuronal mRNAs in seizure and cocaine brain.
Tiruchinapalli DM; Caron MG; Keene JD
J Neurochem; 2008 Dec; 107(6):1529-43. PubMed ID: 19014379
[TBL] [Abstract][Full Text] [Related]
12. HuR Protein in Hepatocellular Carcinoma: Implications in Development, Prognosis and Treatment.
Papatheofani V; Levidou G; Sarantis P; Koustas E; Karamouzis MV; Pergaris A; Kouraklis G; Theocharis S
Biomedicines; 2021 Jan; 9(2):. PubMed ID: 33513829
[TBL] [Abstract][Full Text] [Related]
13. Identification of Small-Molecule Inhibitors of the HuR/RNA Interaction Using a Fluorescence Polarization Screening Assay Followed by NMR Validation.
Wang Z; Bhattacharya A; Ivanov DN
PLoS One; 2015; 10(9):e0138780. PubMed ID: 26390015
[TBL] [Abstract][Full Text] [Related]
14. HuR, a key post-transcriptional regulator, and its implication in progression of breast cancer.
Yuan Z; Sanders AJ; Ye L; Jiang WG
Histol Histopathol; 2010 Oct; 25(10):1331-40. PubMed ID: 20712017
[TBL] [Abstract][Full Text] [Related]
15. Human antigen R and drug resistance in tumors.
Zhou F; Zhang F; Zhou C; Liang M; Cai Z; Lv H; Li W; Wei X
Invest New Drugs; 2019 Oct; 37(5):1107-1116. PubMed ID: 30612309
[TBL] [Abstract][Full Text] [Related]
16. Polyamines regulate the stability of activating transcription factor-2 mRNA through RNA-binding protein HuR in intestinal epithelial cells.
Xiao L; Rao JN; Zou T; Liu L; Marasa BS; Chen J; Turner DJ; Zhou H; Gorospe M; Wang JY
Mol Biol Cell; 2007 Nov; 18(11):4579-90. PubMed ID: 17804813
[TBL] [Abstract][Full Text] [Related]
17. ELAV proteins along evolution: back to the nucleus?
Colombrita C; Silani V; Ratti A
Mol Cell Neurosci; 2013 Sep; 56():447-55. PubMed ID: 23439364
[TBL] [Abstract][Full Text] [Related]
18. The RNA Binding Protein HuR: A Promising Drug Target for Anticancer Therapy.
Wu M; Tong CWS; Yan W; To KKW; Cho WCS
Curr Cancer Drug Targets; 2019; 19(5):382-399. PubMed ID: 30381077
[TBL] [Abstract][Full Text] [Related]
19. Current Evidence and Future Perspectives on HuR and Breast Cancer Development, Prognosis, and Treatment.
Kotta-Loizou I; Vasilopoulos SN; Coutts RH; Theocharis S
Neoplasia; 2016 Nov; 18(11):674-688. PubMed ID: 27764700
[TBL] [Abstract][Full Text] [Related]
20. MAP kinase phosphatase-1 expression is regulated by 15-deoxy-Δ12,14-prostaglandin J2 via a HuR-dependent post-transcriptional mechanism.
Woo JH; Lee JH; Kim H; Choi Y; Park SM; Joe EH; Jou I
Biochim Biophys Acta; 2015 Jun; 1849(6):612-25. PubMed ID: 25805336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
